Annual report 2022

30. Mar 2023 | 1 min read

 

Moss, 30 March 2023

Gentian Diagnostics has today published its annual report for 2022. The annual report and the ESEF file is attached to this stock exchange notice and is also available on www.gentian.com.

IR contact:
Njaal Kind, CFO
njaal.kind@gentian.no 
+47 919 06 525 (mobile)

This information is subject to disclosure requirements pursuant to §5-12 of the Norwegian Securities Trading Act.


586727_5967007LIEEXZXHNM861-2022-12-31-en.zip
86727_GDASA annual report 2022.pdf

You may also read


Feb 12, 2026 - Ole Sørlie

Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Feb 11, 2026 - Ole Sørlie

Update on the development of the NT-proBNP assay

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Feb 11, 2026 - Ole Sørlie

Gentian Diagnostics: Fourth quarter 2025 report

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..